Literature DB >> 5383009

[Jaundice during treatment with rifampicin (12 cases)].

R Lesobre, J Ruffino, L Teyssier, F Achard, G Brefort.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5383009

Source DB:  PubMed          Journal:  Rev Tuberc Pneumol (Paris)        ISSN： 0035-1792


× No keyword cloud information.
  11 in total

1.  Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.

Authors:  A H Diacon; R F Patientia; A Venter; P D van Helden; P J Smith; H McIlleron; J S Maritz; P R Donald
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

2.  Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong.

Authors:  M Aquinas; W G Allan; P A Horsfall; P K Jenkins; W Hung-Yan; D Girling; R Tall; W Fox
Journal:  Br Med J       Date:  1972-03-25

3.  Potentially serious side-effects of high-dose twice-weekly rifampicin.

Authors:  G Poole; P Stradling; S Worlledge
Journal:  Postgrad Med J       Date:  1971-11       Impact factor: 2.401

4.  Potentially serious side effects of high-dose twice-weekly rifampicin.

Authors:  G Poole; P Stradling; S Worlledge
Journal:  Br Med J       Date:  1971-08-07

5.  Rifampicin jaundice.

Authors:  R Gabriel
Journal:  Br Med J       Date:  1971-07-17

6.  Adverse effects of antituberculosis drugs.

Authors:  D J Girling
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

7.  Effect of rifampicin and isoniazid on liver function.

Authors:  S Lal; S N Singhal; D M Burley; G Crossley
Journal:  Br Med J       Date:  1972-01-15

Review 8.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

9.  Fulminant hepatitis during treatment with rifampicin, pyrazinamid and ethambutol.

Authors:  W M van Aalderen; H Knoester; K Knol
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

10.  Stimulation of NADH-dependent microsomal DNA strand cleavage by rifamycin SV.

Authors:  E Kukiełka; A I Cederbaum
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.